Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01584895 · ClinicalTrials.gov registry record · NA

Cardiac Rehabilitation in Patients With Continuous Flow Left Ventricular Assist Devices:Rehab VAD Trial

A NA study, sponsored by Henry Ford Health System.

Completed
Registry status
NA
Development phase
26
Enrollment target

NCT01584895 is a NA study that has completed, run by Henry Ford Health System. The registered enrollment target is 26 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01584895, a NA study, has completed, sponsored by Henry Ford Health System.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target

Study Summary

Cardiac rehabilitation programs improve mortality, functional capacity, and quality of life, for a variety of patients with heart disease. It stands to reason that patients with LVADs might therefore also benefit from the same structured exercise training, education, and clinical surveillance. One potential benefit of cardiac rehabilitation in this patient population is reversal of the skeletal muscle atrophy that occurs due to extended periods of poor peripheral perfusion (i.e. before implantation) and prolonged sedentary behavior. Purpose: The purpose of this proposed study is to examine the effects of a 6-week exercise program on cardiorespiratory fitness, quality of life, and device flow rate in patients with recently implanted LVADs. Methods: 30 patients with recently implanted LVADs will be referred by the Henry Ford Hospital Advanced Heart Failure Program once the patient is deemed appropriate for exercise. Before enrollment into cardiac rehabilitation patients will undergo a six minute walk test and graded exercise stress test on a treadmill to determine exercise capacity. Additionally, a quality of life questionnaire will be given. Following the stress test, patients will be randomized (2 to 1 ratio) into either cardiac rehabilitation or control. Those chosen to be in the control group will be encouraged to maintain daily activities; those in the rehabilitation group will partake in 6 weeks of a standard cardiac rehabilitation program. This will consist of 3 days a week of supervised exercise as well as education regarding diet and lifestyle modifications. At 6 weeks after randomization both groups will again undergo fitness assessments and retake the quality of life questionnaires.

Interventions

  • BEHAVIORAL Cardiac Rehabilitation

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2011-05
Est. Completion 2013-01
Phase NA

Sponsor

Henry Ford Health System

234 total trials

What the Registry Record Tells You About NCT01584895

The ClinicalTrials.gov registry entry for NCT01584895 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cardiac Rehabilitation is the first listed.

NCT01584895 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01584895 about?

NCT01584895 is a clinical study titled "Cardiac Rehabilitation in Patients With Continuous Flow Left Ventricular Assist Devices:Rehab VAD Trial". Cardiac rehabilitation programs improve mortality, functional capacity, and quality of life, for a variety of patients with heart disease. It stands to reason that patients with LVADs might therefore also benefit from the same structured exercise training, education, and clinical surveillance. One p...

What is the current status of trial NCT01584895?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2011-05. Estimated completion is 2013-01.

What interventions are being tested in trial NCT01584895?

The interventions under investigation include: Cardiac Rehabilitation (BEHAVIORAL).

Who is sponsoring clinical trial NCT01584895?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.